India's Generic Drug Producing Company gets a Setback
08 Sep, 2005
According to the new World Trade Organization
patent protection rules that took effect on January
1, 2005 the era of being the world's "copycat"
king of generic drug production is coming to an end
for India.
No longer can Indian companies simply copy drugs patented
after January 1995. It means imitation is not going
to work any longer for the generic
drug producing company of India. In fact, it has
been that way for some time for India's flagship pharmaceutical
companies such as Ranbaxy Laboratories and Dr. Reddy's
Laboratories.
They've already started spending a significant amount
in the key area of research and development, recognizing
the fact that growth will come primarily from their
ability to innovate and bring new drugs to the market.
To read more, log on to… http://edition.cnn.com/2005/WORLD/asiapcf/09/07/india.eye.pharma/
|
